C
Calm Water Therapeutics develops polymer-based therapeutics aimed at treating and preventing various ocular diseases. Their proprietary polymer technology addresses a range of eye disorders, including dry eye disease and complications like ADC-induced corneal toxicity. The company focuses on advancing novel solutions within the ophthalmic therapeutic space.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Calm Water Therapeutics develops polymer-based therapeutics aimed at treating and preventing various ocular diseases. Their proprietary polymer technology addresses a range of eye disorders, including dry eye disease and complications like ADC-induced corneal toxicity. The company focuses on advancing novel solutions within the ophthalmic therapeutic space.